The RGCC (Greece Cancer) test is a revolutionary and highly specialized lab test that can be used to isolate, count, and identify the type of circulating tumor and stem cells in a patient’s bloodstream to assess the cell’s sensitivity to chemotherapy and/or nutritional extracts, and then enable our team to design a personalized treatment program for the patient instead of using a “hit-and-miss” approach using known cancer drugs.
30 ml of the patient’s blood is extracted and expedited to the RGCC labs in Greece.
Within a few weeks, patients receive their detailed information back so with the healthcare provider can make life and health-saving decisions on the best treatment protocols for them.
|Monday – Thursday||9:00 – 5:00|
|Friday||9:00 – 1:00|